SUBJECTS : Drug Safety | Clinical Toxicology | Pharmacology | Pharmacotherapeutic
Therapeutic Advances in Drug Safety: 2022, vol: 13, issue:
- 1)- Mohammed I Danjuma, Oyelola A Adegboye, Ahmed Aboughalia, Nada Soliman, Ruba Almishal, Haseeb Abdul, Mohamad Faisal Hamad Mohamed, Mohamed Nabil Elshafie, Abdulatif AlKhal, Abdelnaser Elzouki, Arwa Al-Saud, Mas Chaponda, Mubarak Arriyo Bidmos. Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis. Therapeutic advances in drug safety. 2022, 13: 20420986221080795
Cited : 9Read More - 2)- Yoojin Noh, Kyu-Nam Heo, Yun Mi Yu, Ju-Yeun Lee, Young-Mi Ah. Trends in potentially inappropriate opioid prescribing and associated risk factors among Korean noncancer patients prescribed non-injectable opioid analgesics. Therapeutic advances in drug safety. 2022, 13: 20420986221091001Cited : 8Read More
- 3)- Georgie B Lee, Christopher Etherton-Beer, Sarah M Hosking, Julie A Pasco, Amy T Page. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review. Therapeutic advances in drug safety. 2022, 13: 20420986221100117Cited : 21Read More
- 4)- Shin Kashima, Koji Sawada, Kentaro Moriichi, Mikihiro Fujiya. A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease. Therapeutic advances in drug safety. 2022, 13: 20420986221100118Cited : 3Read More
- 5)- Yu Yoshida, Sayaka Sasaoka, Mizuki Tanaka, Kiyoka Matsumoto, Misaki Inoue, Riko Satake, Kazuyo Shimada, Ririka Mukai, Takaaki Suzuki, Mari Iwata, Fumiya Goto, Takayuki Mori, Koki Mori, Tomoaki Yoshimura, Mitsuhiro Nakamura. Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database. Therapeutic advances in drug safety. 2022, 13: 20420986221101963Cited : 4Read More
- 6)- Maria Jose Nino-Orrego, Daniela Baracaldo-Santamaría, Claudia Patricia Ortiz, Heyde Patricia Zuluaga, Sthefany Alejandra Cruz-Becerra, Franklin Soler, Andrés M Pérez-Acosta, Daniel Ricardo Delgado, Carlos-Alberto Calderon-Ospina. Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study. Therapeutic advances in drug safety. 2022, 13: 20420986221101964Cited : 4Read More
- 7)- Nadja Albertsen, Tine Gjedde Sommer, Thomas Mikkel Olsen, Anna Prischl, Hans Kallerup, Stig Andersen. Polypharmacy and potential drug-drug interactions among Greenland's care home residents. Therapeutic advances in drug safety. 2022, 13: 20420986221103918Cited : 2Read More
- 8)- Nicole F Clark, Andrew W Taylor-Robinson, Kirsten Heimann. Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir? Therapeutic advances in drug safety. 2022, 13: 20420986221107753Cited : 1Read More
- 9)- Loes Johanna Maria van Herpen-Meeuwissen, Charlotte Linde Bekker, Nicky Cornelissen, Barbara Maat, Hendrikus Antonius Walterus van Onzenoort, Bartholemeus Johannes Fredericus van den Bemt. Patients' views on Self-administration of Medication during hospitalisation: a mixed-methods study. Therapeutic advances in drug safety. 2022, 13: 20420986221107804Cited : 1Read More
- 10)- Irene R Fermont, Ayalah Livneh, Michel Benhamou. Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience. Therapeutic advances in drug safety. 2022, 13: 20420986221112189Cited : 1Read More
- 11)- Abimbola Cole, Peggy Webster, Denny Van Liew, Maribel Salas, Omar Aimer, Marina A Malikova. Safety surveillance and challenges in accelerated COVID-19 vaccine development. Therapeutic advances in drug safety. 2022, 13: 20420986221116452Cited : 12Read More
- 12)- Kaylee M Lukacena, James W Keck, Patricia R Freeman, Nancy Grant Harrington, Mark J Huffmyer, Daniela C Moga. Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists. Therapeutic advances in drug safety. 2022, 13: 20420986221116465Cited : 10Read More
- 13)- Abena Ahwianfoa Yawson, Gordon Abekah-Nkrumah, Grace Adjei Okai, Charles Gyamfi Ofori. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana. Therapeutic advances in drug safety. 2022, 13: 20420986221116468Cited : 7Read More
- 14)- Mary T Antonelli, John S Cox, Cassandra Saphirak, Jerry H Gurwitz, Sonal Singh, Kathleen M Mazor. Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study. Therapeutic advances in drug safety. 2022, 13: 20420986221118143Cited : 3Read More
- 15)- Annette Rudolph, Joseph Mitchell, Jim Barrett, Helena Sköld, Henric Taavola, Nils Erlanson, Carlos Melgarejo-González, Qun-Ying Yue. Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge. Therapeutic advances in drug safety. 2022, 13: 20420986221118972Cited : 20Read More
- 16)- Nina-Kristin Mann, Sven Schmiedl, Achim Mortsiefer, Veronika Bencheva, Susanne Löscher, Manuela Ritzke, Eva Drewelow, Gregor Feldmeier, Sara Santos, Stefan Wilm, Petra A Thürmann, . Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care. Therapeutic advances in drug safety. 2022, 13: 20420986221122684Cited : 4Read More
- 17)- Sofia Khaja. Increasing patient involvement through self-administration of medication. Therapeutic advances in drug safety. 2022, 13: 20420986221124699Cited : 1Read More
- 18)- Sylvia Lucas, Jessica Ailani, Timothy R Smith, Ahmad Abdrabboh, Fei Xue, Marco S Navetta. Pharmacovigilance: reporting requirements throughout a product's lifecycle. Therapeutic advances in drug safety. 2022, 13: 20420986221125006Cited : 25Read More
- 19)- Daniela Baracaldo-Santamaría, Maria José Trujillo-Moreno, Andrés M Pérez-Acosta, John Edwin Feliciano-Alfonso, Carlos-Alberto Calderon-Ospina, Franklin Soler. Definition of self-medication: a scoping review. Therapeutic advances in drug safety. 2022, 13: 20420986221127501Cited : 16Read More
- 20)- Kunlu Shen, Yu Gu, Yu Wang, Yajie Lu, Yueyan Ni, Huanhiuan Zhong, Yi Shi, Xin Su. Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases. Therapeutic advances in drug safety. 2022, 13: 20420986221127503Cited : 12Read More
- 21)- Kayeong Shin, Jiwoo Yang, Yeuni Yu, Eunjeong Son, Kihun Kim, Yun Hak Kim. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies. Therapeutic advances in drug safety. 2022, 13: 20420986221129335Cited : 2Read More
- 22)- Beth L Nordstrom, Bin Cai, Fabio De Gregorio, Lu Ban, Kathy H Fraeman, Yuki Yoshida, Trevor Gibbs. Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study. Therapeutic advances in drug safety. 2022, 13: 20420986221135931Cited : 2Read More
- 23)- Eva Amenta, Larissa Grigoryan, Laura Dillon, Casey Hines-Munson, John Van, Barbara Trautner. A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States. Therapeutic advances in drug safety. 2022, 13: 20420986221143265Cited : 3Read More
- 24)- Shuang Chai, Jing-Lun Zhan, Li-Mei Zhao, Xiao-Dong Liu. Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS. Therapeutic advances in drug safety. 2022, 13: 20420986221143266Cited : 9Read More
- 25)- Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu, Biyun Wang. Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data. Therapeutic advances in drug safety. 2022, 13: 20420986221146411Cited : 1Read More
